Low cholesterol, cognitive function and Alzheimer's disease in a community population with cognitive impairment

Journal of Nutrition, Health and Aging

Volumn 6, Issue 5, 2002, Pages 320-323

  Kim, J M ^a   Stewart, R ^b   Shin, I S ^c   Yoon, J S ^c  

^a Chosun University   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Alzheimer disease; Cholesterol; Cognitive decline; Cognitive impairment; Dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIET RESTRICTION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SAMPLING; SCORING SYSTEM;

EID: 0036959786     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Prince M., Lovestone S., Cervilla J., et al., The association between APOE and dementia is mediated neither by vascular disease nor its risk factors in an aged cohort of survivors with hypertension. Neurology, 2000, 54:397-402.
2. Stewart R., Richards R., Brayne C., Mann A., Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J. Am. Geriatr. Soc., 2001, 49:263-269.
3. Kalmijn S., Launer L.J., Ott A., Witterman J.C.M., Hofman A., Breteler M.M.B., Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol., 1997, 42:776-782.
4. Cerhan J.R., Folsom A.R., Mortimer J.A., et al., Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology, 2000, 44:95-105.
5. Romas S.N., Tang M.-X., Berglund L., Mayeux R., APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology, 1999, 53:517-521.
6. Notkola I.L., Sulkava R., Pekkanen J., et al., Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology, 1998, 17:14-20.
7. Park J.H., Kwon Y.C., Modification of the mini-mental state examination for use in the elderly in a non-western society: Part I. Development of Korean version of Mini-Mental State Examination. Int. J. Geriatr. Psychiatry, 1990, 5:381-387.
8. Park J.H., Park Y.N., Ko H.J., Modification of the Mini-Mental State Examination for use in the elderly in a non-western society: Part II. Cutoff points and their diagnostic validities. Int. J. Geriatr. Psychiatry, 1991, 6:875-882.
9. Blessed G., Tomlinson B.E., Roth M., The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br. J. Psychiatry, 1968, 114:797-811.
10. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorder, 4th Ed. Washington D.C., 1994.
11. Mahoney F.I., Barthel D.W., Functional evaluation: the Barthel Index. Md. St. Med. J., 1965, 14:61-65.
12. Refolo L.M., Pappolla M.A., Malester B., et al., Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Disease, 2000, 7:321-331.
13. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J., White L.R., Untreated blood pressure level is inversely related to cognitive functioning: The Framingham study. Am. J. Epidemiol., 1993, 138:353-364.
14. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. JAMA., 1995, 274:1846-1851.
15. Guo Z., Viitanen M., Fratiglioni L., Winblad B., Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ., 1996, 312:805-808.
16. Skoog I., Lernfelt B., Landahl S., et al., 15-year longitudinal study of blood pressure and dementia. Lancet, 1996, 347:1141-1145.